Cargando…
Divide and conquer: towards isoform-specific diagnosis and therapy of KRAS-mutant lung cancer
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
AME Publishing Company
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10326791/ https://www.ncbi.nlm.nih.gov/pubmed/37425414 http://dx.doi.org/10.21037/tlcr-23-72 |
| _version_ | 1785069496137940992 |
|---|---|
| author | Allemann, Anna T. Gautschi, Oliver |
| author_facet | Allemann, Anna T. Gautschi, Oliver |
| author_sort | Allemann, Anna T. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10326791 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | AME Publishing Company |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-103267912023-07-08 Divide and conquer: towards isoform-specific diagnosis and therapy of KRAS-mutant lung cancer Allemann, Anna T. Gautschi, Oliver Transl Lung Cancer Res Editorial Commentary AME Publishing Company 2023-05-24 2023-06-30 /pmc/articles/PMC10326791/ /pubmed/37425414 http://dx.doi.org/10.21037/tlcr-23-72 Text en 2023 Translational Lung Cancer Research. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) . |
| spellingShingle | Editorial Commentary Allemann, Anna T. Gautschi, Oliver Divide and conquer: towards isoform-specific diagnosis and therapy of KRAS-mutant lung cancer |
| title | Divide and conquer: towards isoform-specific diagnosis and therapy of KRAS-mutant lung cancer |
| title_full | Divide and conquer: towards isoform-specific diagnosis and therapy of KRAS-mutant lung cancer |
| title_fullStr | Divide and conquer: towards isoform-specific diagnosis and therapy of KRAS-mutant lung cancer |
| title_full_unstemmed | Divide and conquer: towards isoform-specific diagnosis and therapy of KRAS-mutant lung cancer |
| title_short | Divide and conquer: towards isoform-specific diagnosis and therapy of KRAS-mutant lung cancer |
| title_sort | divide and conquer: towards isoform-specific diagnosis and therapy of kras-mutant lung cancer |
| topic | Editorial Commentary |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10326791/ https://www.ncbi.nlm.nih.gov/pubmed/37425414 http://dx.doi.org/10.21037/tlcr-23-72 |
| work_keys_str_mv | AT allemannannat divideandconquertowardsisoformspecificdiagnosisandtherapyofkrasmutantlungcancer AT gautschioliver divideandconquertowardsisoformspecificdiagnosisandtherapyofkrasmutantlungcancer |